NSESpurt in Volume4d ago · 2 Sept 2026, 05:29 pm
Spurt in Volume
Caplin Point Laboratories Limited · CAPLIPOINT
✦ AI SummaryRegulatory
Caplin Point Laboratories Limited has responded to a query from the National Stock Exchange regarding a significant increase in trading volume of its shares, stating that the increase is market-driven and that it has made all requisite disclosures.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Significant increase in volume has been observed in Caplin Point Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Caplin Point Laboratories Limited has submitted their response.
Attachments (1)
📄pdf
Download →
CAPLINPOINT_02092026172729_Spurt_in_Volume_sd.pdf
View document text
September 02, 2026
BSE Limited National Stock Exchange of India Ltd.,
Department of Corporate Relationship Department of Corporate Services
1st Floor, New Trade Ring, Rotunda Building Exchange Plaza, 5th Floor,
Phiroze Jeejeebhoy Towers C-1, Block G,Bandra Kurla Complex,
Dalal Street, Mumbai- 400001 Bandra (E),Mumbai – 400 051
Scrip Code: 524742 S c r i p C o d e : C A P L I P O I N T .
Dear Sir/Madam,
Sub: Clarification with respect to Spurt in Volume- NSE email dated September 01, 2026
We refer to the captioned email received from National Stock Exchange of India Limited ("NSE") on
September 01, 2026, regarding a significant increase in the trading volume of the equity shares of
Caplin Point Laboratories Limited ("the Company") across exchanges in the recent past.
We would like to inform you that the company has duly made all requisite disclosures in compliance
with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
("SEBI LODR Regulations"), including all material events and price sensitive information having a
bearing on the operations/performance of the Company. The Company confirms that it has not
withheld any material/price sensitive information that in its opinion would have bearing on the
volume/price behaviour of the shares.
Accordingly, the said increase in trading volume of shares of the Company is purely market driven and
the Company is not aware of any specific reasons contributing to the same.
The Company further confirms its continued commitment to comply with all applicable disclosure
requirements under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, as amended from time to time.
This is for your kind information and records.
Kindly acknowledge the receipt.
Thanking You,
Sincerely yours,
For Caplin Point Laboratories Limited
Venkatram G
General Counsel & Company Secretary
Membership No A23989